Осложнения, побочные эффекты и особенности клинического применения мобилизованных аутологичных гемопоэтических стволовых клеток в комплексной терапии пациентов с повреждением спинного мозга
С. Н. Авдейкин, А. С. Брюховецкий · Genes and Cells · 2011
Stem cell therapy finds ever-widening application in restoration of neural tissue, and particularly spinal cord injuries (SCI). Still, safety problems are far from being solved and adverse effects of the therapy remain understudied. The goal of the study is to evaluate safety and to detect complications and specific characteristics of clinical application of mobilized autologous hematopoietic stem cells (AHSC) in complex therapy of SCI. The complications have been studied at all stages of SCI therapy: at the stage of AHSC mobilization to peripheral blood, separation stage and cell therapy. It was detected that overall complication rate achieved 75%. Our study showed that AHSC therapy of SCI demands specific training of the medical staff and must be administered in multi-field hospital under the supervision of hematologist, intensivist and neurologist experienced in highly technological methods of treatment.
Cited by 0 works.
Authors
References
- Epidemiology, Demographics, and Pathophysiology of Acute Spinal Cord Injury
- Control of the Embryonic Stem Cell State
- A Global Perspective on Spinal Cord Injury Epidemiology
- Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor
- Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program
- Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors
- Epidemiology of traumatic spinal cord injury in Tianjin, China
- Epidemiology of Spinal Cord Injury In Chiloren And Adolescents
- Adult stem cells in the treatment of autoimmune diseases
- Migration, fate and in vivo imaging of adult stem cells in the CNS